In our comparison of Contrave Vs. Ozempic, Forbes Advisor breaks down the similarities and differences between Contrave, ...
The public held 25.89% of Shaily Engineering at the end of June. By September, it held 23.34%. FIIs went up by 1.25 ...
Think School on MSN
India wants to make Ozempic-like drugs cheaper - but the injection pen could be a bigger problem than the medicine
Ozempic and Mounjaro have transformed the market for diabetes and weight-management medications, generating enormous business ...
FAKE weight loss jabs like ‘reta’ could increase your appetite rather than shrink it, a new study suggests. Slimmers ...
GLP-1 weight-loss injections made by a compounding pharmacy previously warned by the FDA have been recalled nationwide after ...
In insulin-naive adults with T2D, once-weekly icodec plus semaglutide vs insulin glargine U100 showed superior glycemic control and weight loss.
With rising incidences of diabetes in India, medications have evolved as has the underlying approach to managing the ...
What are key trends for injectable drugs and the related market impact? From switches from IV-administered to subcutaneous ...
For those seeking GLP-1 medication prescriptions and treatment, telehealth can reduce some of the barriers in starting and ...
Lemonaid Health offers cash-pay telehealth and prescription support for a variety of issues, including weight loss. Their program focuses on tailored GLP-1 injection management and may be a good fit ...
Amylin analog obesity therapeutics market to grow from USD 140.0 Mn in 2026 to USD 1,324.9 Mn by 2036 at a 25.2% CAGR. Get segment, region & competitor insights.
GLP-1 microdosing is a viral trend of people experimenting with smaller-than-recommended doses to lose weight. Dr Ambrish Mithal, the group chairman and head of endocrinology and diabetology at Max ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results